Table 2 Association between angiogenic biomarker concentrations among 57 participants with HIV compared to 57 without HIV (n = 57) in ZAPPS
From: Circulating angiogenic factors and HIV among pregnant women in Zambia: a nested case–control study
HIV- | HIV + | β | 95% CI | p-value | β* | 95% CI* | p-value* | |
|---|---|---|---|---|---|---|---|---|
Median (IQR) | Median (IQR) | |||||||
sEng | 2061.51 (1306.36 – 3100.25) | 2055.37 (1340.71 – 3026.46) | 0.002 | -0.22—0.22 | 0.99 | 0.01 | -0.23—0.26 | 0.92 |
PlGF | 10.24 (7.91 – 14.87) | 7.63 (5.07 – 13.15) | -0.23 | -0.46—0.00 | 0.06 | -0.20 | -0.46—0.05 | 0.12 |
sFLT-1 | 2055.63 (1619.70 – 2735.15) | 1647.88 (1140.42 – 2641.84) | -0.22 | -0.45—0.00 | 0.05 | -0.06 | -0.30—0.18 | 0.63 |
PlGF/sFLT-1 | 0.005 (0.003 – 0.009) | 0.005 (0.003 – 0.008) | -0.004 | -0.30 – 0.29 | 0.98 | -0.14 | -0.47 – 0.18 | 0.38 |